News Focus
News Focus
Followers 59
Posts 7866
Boards Moderated 0
Alias Born 05/18/2007

Re: oakrock post# 83625

Monday, 10/22/2018 8:08:07 AM

Monday, October 22, 2018 8:08:07 AM

Post# of 108195
Upcoming things to look forward to....

Anticipated Milestones Over the Next 12 Months with
TARGET
ADXS-HPV (axalimogene filolisbac) • Announce planned Investigator Sponsored Trial in Head and Neck Cancer Q4 2018
ADXS-HOT Prostate • IND Submission Q4 2018
ADXS-PSA • MetastaticProstatePh1/2Combinationwithpembrolizumab-- Part B Monotherapy Combination Therapy Data (12-mo PFS and OS) Q1 2019
ADXS-NEO • Clinical data from initial cohort (safety, immune response) 1H 2019
ADXS-HOT NSCLC • Clinical data from initial cohort (safety, immune response) 1H 2019
ADXS-HOT Bladder • IND Submission 2019
ADXS-HOT Construct #4 • IND Submission Selected from Breast, ovarian, MSS-CRC, H&N 2019


Show me the money in any of these.


ADXS Business Plan for 2019 : Raising more capital

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today